BREAKING SILOS TO TRANSFORM WOMEN’S HEALTH THROUGH MEDTECH Inaugural Summit discusses new evidence in inequities affecting diagnosis, treatment and innovation
With
Jasjit Baveja PhD,
Director of Regulatory and Industry Policy,
Medical Technology Association of Australia (MTAA)
SEGMENT
Filmed in Sydney | July 2026
In an interview with Australian Health Journal, Jasjit Baveja, Director of Regulatory and Industry Policy at the Medical Technology Association of Australia (MTAA), highlighted the growing importance of medical technology in addressing longstanding inequities in women’s health.
Drawing on the outcomes of the inaugural MTAA Women’s Health MedTech Summit, she explained how the event brought together clinicians, researchers, industry leaders, regulators, investors, government representatives and patient advocates to tackle complex challenges through a collaborative approach.
Baveja said the summit was intentionally designed to break down traditional barriers between stakeholders, noting that, “it doesn’t matter who it was, they were all describing different parts of the same problem.” Discussions extended well beyond reproductive and sexual health to examine conditions that affect women exclusively, differently or disproportionately across every stage of life.
The summit identified several key barriers, including delayed diagnosis, gaps in clinical evidence, medical device design that often fails to account for women’s needs, and regulatory and reimbursement challenges. Baveja also highlighted compelling statistics that demonstrate persistent gender disparities in research and healthcare, reinforcing the need for greater investment in women’s health across the entire medical technology lifecycle.
Importantly, she said the discussions reinforced that women’s health is no longer a niche issue, but one with significant health, workforce, economic and innovation implications.
Looking ahead, Baveja said there was “strong support to move from conversation to action,” with MTAA committing to establish a Women’s Health Policy Group and develop a white paper outlining barriers, opportunities and policy recommendations to improve health outcomes for Australian women.
Source: Adapted from transcript
Media access credit: Medical Technology Association of Australia (MTAA)
-
New option for management of high-risk soft tissue sarcoma of the limb
SARC032 is the first completed randomised clinical trial of its kind and has demonstrated compelling evidence to integrate immunotherapy, with the standard treatment regimen of radiotherapy and surgery for patients with grade 2 or 3, stage III soft tissue sarcoma of the limb.
-
Bringing the circular healthcare economy to life
Neroli Manning is the Managing Director for Cardinal Health Australia & New Zealand (ANZ). With over 30 years of experience in the healthcare industry, Neroli is a transformative leader known for her people-first, customer-centric leadership style.
-
Lower back pain presentations in Emergency Department
Around 70 percent of people will experience lower back pain at some stage of their lives.
A recent study conducted over five years found one in three people suffering from lower back pain presented to hospital via an ambulance.In many cases people will attend an emergency department when they feel they can’t manage their pain or when treatments by community healthcare services have been ineffective or inaccessible due to location or cost. However, 90 per cent of people can get better on their own in a few weeks.
